Progress of RAGE Molecular Imaging in Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by senile plaques (SPs), which are caused by amyloid beta (Aβ) deposition and neurofibrillary tangles (NFTs) of abnormal hyperphosphorylated tau protein. The receptor for advanced glycation end products (RAGE) binds to...
Main Authors: | Yanyan Kong, Cuiping Liu, Yinping Zhou, Jingxuan Qi, Chencheng Zhang, Bomin Sun, Jiao Wang, Yihui Guan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2020.00227/full |
Similar Items
-
Aβ plaques
by: Lary C Walker
Published: (2020-10-01) -
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
by: Evelin L. Schaeffer, et al.
Published: (2011-01-01) -
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
by: Jana Crum, et al.
Published: (2018-10-01) -
Liposome delivery systems for the treatment of Alzheimer’s disease
by: Ross C, et al.
Published: (2018-12-01) -
Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease
by: Gao Kuo, et al.
Published: (2014-01-01)